Heightened Government Scrutiny
CD of Teleconference with Q&A
|
Conducted on Thursday, June 26, 2008
Now available on CD |
Hospital Litigation Reporter and New York Health Law Update
In the wake of major recalls of new medications and medical devices that allegedly harmed patients and a 2007 Inspector General Report that the FDA had failed to provide adequate oversight of clinical trials, various government agencies are taking a hard look at clinical trials.
It is critical that physicians and hospitals participating in clinical research trials immediately review and update their policies and procedures, understand the common legal issues arising in clinical trials, and take steps to minimize their liability for compliance shortfalls.
Listen and participate from your telephone as our panel of healthcare attorneys examines the legal implications of conducting clinical research trials and best practices for hospitals and physicians to avoid mistakes that can create liability exposure.
The panel included:
Carol A. Poindexter, Partner, Shook Hardy & Bacon, Kansas City, Mo. She is Co-Chair of the firm's Health Law Industry and assists medical providers and pharmaceutical manufacturers in managing fraud and abuse risks. She is a frequent speaker on fraud and abuse.
LaDale K. George, Partner, Foley & Lardner, Chicago. He concentrates on FDA and HHS clinical research and trial compliance. He assists clients in the proactive design, implementation, and defense of optimal clinical research programs.
R. Wayne Bond, Attorney at Law, Womble Carlyle Sandridge & Rice, Atlanta. He represents clinical trial sponsors in criminal and civil litigation in state and federal court and has been involved in the early stages of regulatory and criminal investigations of clinical trials.
The panel reviewed these and other key questions:
- What clinical trial activities give rise to potential False Claims Act liability?
- What are the Anti-Kickback risks of conducting clinical trials?
- What should providers and hospitals do now to limit their liability for the risks of conducting clinical trials?
- What are the unresolved issues concerning Medicare billing for clinical trials?
Following the speaker presentations, you’ll have an opportunity to get answers to your specific questions during the interactive Q&A.
*******************************************************************************
TELECONFERENCE CD
Purchase a CD-ROM of the full conference proceedings, including Q&A and PDF files of all handouts (available 10 days after the program).
- Teleconference CD Price $297
- With Teleconference Registration – an additional $75 (plus $9.45 S&H)
CLE credit is available for an additional $65 each for attorneys seeking CLE credits for NY or CT.
Other states may grant CLE credits for listening to this CD — check with your state about applying for self-study credit on CD-listening.